Unlock instant, AI-driven research and patent intelligence for your innovation.

VGF fusion polypeptides

a technology of fusion polypeptides and polypeptides, applied in the field of vgf polypeptides and selective binding agents, can solve problems such as the imbalance of energy intak

Inactive Publication Date: 2007-01-11
AMGEN INC
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides isolated polypeptides that have specific activities and can be used for various applications. These polypeptides can be obtained by modifying or deleting certain parts of the amino acid sequence. The invention also provides fusion polypeptides that combine the polypeptides with other molecules or proteins. Additionally, the invention provides selective binding agents that specifically target the polypeptides. Overall, the invention provides a wide range of polypeptides with different activities and uses for various applications.

Problems solved by technology

Obesity and anorexia are disruptions of energy homeostasis, resulting from imbalances between energy intake and expenditure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • VGF fusion polypeptides
  • VGF fusion polypeptides
  • VGF fusion polypeptides

Examples

Experimental program
Comparison scheme
Effect test

example 1

Production of Anti-VGF Polypeptide Antibodies

[0262] Antibodies against VGF polypeptides were produced by injecting rabbits with VGF polypeptides synthesized by the Amgen Boulder Peptide Technology group using standard peptide synthesis protocols. Following peptide synthesis, VGF polypeptides from different batches were pooled and lyophilized. The peptide content for each VGF polypeptide was determined by hydrolysis with HCl.

[0263] To prepare polyclonal anti-VGF polypeptide antibodies from VGF polypeptides (VGF-1; SEQ ID NO: 1 or VGF-2; SEQ ID NO: 4; Table I) lacking cysteine residues, 5 mg of a VGF polypeptide and 0.5 ml of Imject® EDC Conjugation Buffer (Pierce, Rockford, Ill.) were transferred to a 2 ml vial, and the mixture was vortexed. A 20 mg vial of Imject® Keyhole Limpet Hemocyanin (Pierce) was diluted in 2 ml sterilized water, and 0.5 ml of this solution was added to the VGF polypeptide solution. Following the addition of Keyhole Limpet Hemocyanin, 0.1 ml of EDC (10 mg of...

example 2

Biological Activity of VGF Polypeptide in Knockout Mice

[0269] The biological activity of VGF polypeptides in knockout mice was analyzed using VGF polypeptides synthesized by the Amgen Boulder Peptide Technology group using standard peptide synthesis protocols. Following peptide synthesis, VGF polypeptides from different batches were pooled and lyophilized. The peptide content for each VGF polypeptide was determined by hydrolysis with HCl.

[0270] VGF gene knockout mice were obtained from Steve Salton of Mt. Sinai School of Medicine, New York, N.Y. Prior to administration of VGF polypeptide, knockout mice were housed under LD 12:12 conditions (i.e., 12 hours of light and 12 hours of dark). Twenty-four hours before VGF polypeptide injection, knockout mice were individually caged and moved to a temporary housing room where the mice were kept for the remainder of the experiment under LD 12:12 conditions.

[0271] VGF polypeptide was administered to knockout mice twice daily (at 9:00 a.m. ...

example 3

VGF Polypeptide-Fc Fusion Proteins

[0273] VGF polypeptides are expressed as fusion proteins with a human immunoglobulin IgG heavy chain Fc region at their carboxyl- or amino-terminus. Using appropriate PCR primers and standard PCR amplification procedures, VGF polypeptide-Fc fusion constructs are prepared by fusing in-frame a DNA sequence coding for the Fc region of human IgGI with that encoding VGF-1 (SEQ ID NO: 1), VGF-1b (SEQ ID NO: 3), or VGF-2 (SEQ ID NO: 4) polypeptide.

[0274] VGF polypeptide-Fc fusion products generated by PCR are digested with the restriction endonucleases Nde I and Bam HI, ligated into the vector pAMG21, and then transformed into competent E. coli strain 2596 cells using standard techniques. Clones are screened for the ability to produce the recombinant protein product and to possess the gene fusion having the correct nucleotide sequence.

[0275] Bacterial cultures containing the Fc fusion constructs in the E. coli strain GM221 are grown at 37° C. in Luria B...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present invention provides novel VGF polypeptides and selective binding agents. The invention also provides host cells and methods for producing VGF polypeptides. The invention further provides VGF pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and / or prevention of diseases, conditions, and disorders associated with VGF polypeptides.

Description

FIELD OF THE INVENTION [0001] This invention relates to novel VGF polypeptides and selective binding agents. The invention also relates to host cells and methods for producing VGF polypeptides. The invention further relates to VGF pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and / or prevention of diseases, conditions, and disorders associated with .VGF polypeptides. BACKGROUND OF THE INVENTION [0002] VGF is a secreted polypeptide that is found in neurons and endocrine cells. Canu et al., 1997, Genomics, 45:443-46. VGF is found in the hypothalamus, and is regulated in the brain by electrical activity, injury, and the circadian clock. The hypothalamus has been shown to play an important role in the regulation of food intake and energy output, and damage to the hypothalamus has been shown to effect both appetite and body weight. Schwartz et al., 1995, Am. J. Physiol., 269:949-57. VGF also has been found to play a role in metabolism. [0003] The nucl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07K14/475C12Q1/68G01N33/53C07H21/04C12P21/06A61K38/00C07K14/47
CPCA61K38/00C07K2319/00C07K14/47A61P3/00
Inventor YAN, HAIBOONE, THOMAS CHARLES
Owner AMGEN INC